Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2018
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinomaMichele Reni, Silvia Zanon, Gianpaolo Balzano, et al.Clinical and Translational Radiation Oncology|July 24, 2019
Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression indexClaudio Fiorino, Paolo Passoni, Anna Palmisano, et al.International Journal of Radiation Oncology, Biology, Physics|June 25, 2013
Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumorPaolo Passoni, Claudio Fiorino, Najla Slim, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2018
A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancerClaudio Fiorino, Calogero Gumina, Paolo Passoni, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2008
Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experienceVincenzo Valentini, Felipe Calvo, Michele Reni, et al.Frontiers in Endocrinology|July 11, 2024
Pelvic ultrasound and pubertal attainment in girls with sexual precocity: the pivotal role of uterine volume in predicting the timing of menarcheAlessandro Cattoni, Gianni Russo, Giulia Capitoli, et al.International Journal of Radiation Oncology, Biology, Physics|June 13, 2018
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal CancerNicola Dinapoli, Brunella Barbaro, Roberto Gatta, et al.BMC Cancer|June 13, 2019
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survivalAlessio G Morganti, Francesco Cellini, Milly Buwenge, et al.Breast (Edinburgh, Scotland)|December 16, 2020
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?Andrei Fodor, Chiara Brombin, Paola Mangili, et al.Pageof 6